Acupuncture for Generalized Anxiety Disorder
Efficacy of Different Electroacupuncture Parameters for Generalized Anxiety Disorder: A Randomized Controlled Trial
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Xiaoting Wu, Doctor
- Numero di telefono: +8618196671636
- Email: xiaotwu@163.com
Luoghi di studio
-
-
Zhejiang
-
Hangzhou, Zhejiang, Cina
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Descrizione
Inclusion Criteria:
Only those who meet the following four criteria simultaneously can be included in this study:
- Meet the diagnostic criteria for GAD;
- Between 18 and 60 years old;
- Conscious and able to communicate normally;
- Have good compliance, be willing to cooperate with the study, and sign the informed consent form.
Exclusion Criteria:
Exclude patients meeting any of the following criteria:
- Organic mental disorder, schizophrenia, bipolar disorder, mania/other psychoses, alcohol/drug addiction, current drug use disorder/lifetime drug abuse, post-stroke/postpartum anxiety;
- History of suicidal behavior or severe suicidal tendency;
- Pregnancy or breastfeeding;
- Mental retardation, unable to cooperate;
- Electroacupuncture contraindications: bleeding tendency, coagulation dysfunction, internal metal implants;
- Participation in other clinical trials within 1 month.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Triplicare
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Comparatore fittizio: sham electroacupuncture group (SEA group)
In the SEA group, shallow punctures were made at the points 1 cm outward/radially from bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6), and Sishencong (EX-HN1) respectively, and then the power was cut off after connecting the electro - acupuncture device.Each treatment lasts 30 minutes, with 3 treatments per week for 4 consecutive weeks, totaling 12 treatments.
|
After connecting the electro - acupuncture device, the power was cut off for 30 minutes each time.Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.
Needles with a specification of 0.25×25mm were selected.
Manual acupuncture is performed at the acupoints of Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
|
|
Sperimentale: 2Hz continuous wave electroacupuncture group (2Hz EA group)
Needles are routinely inserted at bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electroacupuncture is applied to bilateral Shenmen-Neiguan pairs, with intensity adjusted to subject tolerance, and frequencies of 2Hz.
30 minutes per session, 3 sessions weekly for 4 consecutive weeks, 12 sessions total.
|
Needles with a specification of 0.25×25mm were selected.
Manual acupuncture is performed at the acupoints of Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electro-acupuncture device was connected to the bilateral Shenmen (HT7) and Neiguan (PC6) acupoints.
The intensity was set to the level that the subjects could tolerate, and the frequencies were 2Hz for 30 minutes each time.
Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.
|
|
Sperimentale: 100Hz continuous wave electroacupuncture group (100Hz EA group)
Needles are routinely inserted at bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electroacupuncture is applied to bilateral Shenmen-Neiguan pairs, with intensity adjusted to subject tolerance, and frequencies of 100Hz.
30 minutes per session, 3 sessions weekly for 4 consecutive weeks, 12 sessions total.
|
Needles with a specification of 0.25×25mm were selected.
Manual acupuncture is performed at the acupoints of Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electro-acupuncture device was connected to the bilateral Shenmen (HT7) and Neiguan (PC6) acupoints.
The intensity was set to the level that the subjects could tolerate, and the frequencies were 100Hz for 30 minutes each time.
Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.
|
|
Sperimentale: 2Hz/100Hz dense-disperse wave electroacupuncture group (2Hz/100Hz EA group)
Needles are routinely inserted at bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electroacupuncture is applied to bilateral Shenmen-Neiguan pairs, with intensity adjusted to subject tolerance, and frequencies of 100Hz.
30 minutes per session, 3 sessions weekly for 4 consecutive weeks, 12 sessions total.
|
Needles with a specification of 0.25×25mm were selected.
Manual acupuncture is performed at the acupoints of Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electro-acupuncture device was connected to the bilateral Shenmen (HT7) and Neiguan (PC6) acupoints.
The intensity was set to the level that the subjects could tolerate, and the frequencies were 2Hz/100Hz for 30 minutes each time.
Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
the score of Hamilton anxiety rating scale, HAMA
Lasso di tempo: week 0, week 4, week 8 and week 16 after enrollment
|
This scale consists of 14 items.
Trained physicians or assessors conduct a semi-structured interview to rate the subject's recent anxiety symptoms.
The items cover two major dimensions: psychic anxiety (e.g., tension, fear) and somatic anxiety (e.g., muscle tension, cardiovascular symptoms).A higher score indicates more severe symptoms, with 7 set as the cut-off value.
|
week 0, week 4, week 8 and week 16 after enrollment
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
the score of Zung self-rating anxiety scale, SAS
Lasso di tempo: week 0, week 4, week 8 and week 16 after enrollment
|
This rating scale contains 20 items, and subjects complete the self-assessment independently without external interference.
The standard score ranges from 25 to 100.
A higher SAS score indicates more severe symptoms, with 53 set as the cut-off value.
|
week 0, week 4, week 8 and week 16 after enrollment
|
|
the score of Pittsburgh sleep quality index, PSQI
Lasso di tempo: week 0, week 4, week 8 and week 16 after enrollment
|
PSQI is commonly used to assess the sleep quality of participants over the past month.
The total score ranges from 0 to 21.
A higher PSQI score indicates poorer sleep quality, with a cut-off value of 7.
|
week 0, week 4, week 8 and week 16 after enrollment
|
|
the score of Short form-12 health survey, SF-12
Lasso di tempo: week 0, week 4, week 8 and week 16 after enrollment
|
This scale consists of 12 items, which is used to evaluate the recent health status of subjects, covering dimensions including physical function, pain, vitality, and social function.
A higher score indicates better health status, and a standard score below 50 indicates that the health status is below the average level.
|
week 0, week 4, week 8 and week 16 after enrollment
|
Altre misure di risultato
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
Lasso di tempo: From enrollment to the end of treatment at 4 weeks
|
Details of all adverse events will be recorded on the Case Report Form (CRF).
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 after the completion of the trial.
|
From enrollment to the end of treatment at 4 weeks
|
|
acupuncture compliance rate
Lasso di tempo: 4 weeks after treatment
|
At the end of the acupuncture intervention (end of week 4), compliance will be evaluated with the formula: Compliance Rate = (actual treatment times/total treatment times) *100%.
|
4 weeks after treatment
|
|
the level of Heart Rate Variability
Lasso di tempo: week 0 and week 6 after enrollment
|
After obtaining the consent of the subjects, the level of Heart Rate Variability data will be collected before and after the intervention to further explore the anti - anxiety mechanism of electroacupuncture.
|
week 0 and week 6 after enrollment
|
Collaboratori e investigatori
Sponsor
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- MR-33-25-070485
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .